Next Article in Journal
Continuous versus Intermittent Enteral Tube Feeding for Critically Ill Patients: A Prospective, Randomized Controlled Trial
Next Article in Special Issue
Effect of Chronic Moderate Caloric Restriction on the Reproductive Function in Aged Male Wistar Rats
Previous Article in Journal
Associations between Dietary Patterns and Cardiometabolic Risk Factors—A Longitudinal Analysis among High-Risk Individuals for Diabetes in Kerala, India
Previous Article in Special Issue
Long-Term Outcomes of in Utero Ramadan Exposure: A Systematic Literature Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 14
Issue 3
10.3390/nu14030663
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Nutraceuticals: A New Challenge against Cadmium-Induced Testicular Injury

by
Herbert Ryan Marini
1,†,
Antonio Micali
2,†,
Giovanni Squadrito
1,
Domenico Puzzolo
3,
José Freni
3,*,
Pietro Antonuccio
2 and
Letteria Minutoli
1
1
Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy
2
Department of Human Pathology of Adult and Childhood, University of Messina, 98125 Messina, Italy
3
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 98125 Messina, Italy
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Nutrients 2022, 14(3), 663; https://doi.org/10.3390/nu14030663
Submission received: 29 December 2021 / Revised: 27 January 2022 / Accepted: 1 February 2022 / Published: 4 February 2022
(This article belongs to the Special Issue Diet and Fertility Status: Relevance in Health and Disease)
Browse Figures
Review Reports Versions Notes

Abstract

:
Cadmium (Cd) is a widespread heavy metal and a ubiquitous environmental toxicant. For the general population, the principal causes of Cd exposure are cigarette smoking, air pollution and contaminated water and food consumption, whereas occupational exposure usually involves humans working in mines or manufacturing batteries and pigments that utilize Cd. The aim of the present review is to evaluate recent data regarding the mechanisms of Cd-induced testicular structural and functional damages and the state of the art of the therapeutic approaches. Additionally, as the current literature demonstrates convincing associations between diet, food components and men’s sexual health, a coherent nutraceutical supplementation may be a new valid therapeutic strategy for both the prevention and alleviation of Cd-induced testicular injury. The toxic effects on testes induced by Cd include many specific mechanisms, such as oxidative stress, inflammation and apoptosis. As no specific therapy for the prevention or treatment of the morbidity and mortality associated with Cd exposure is available, the development of new therapeutic agents is requested. Dietary strategies and the use of nutraceuticals, particularly abundant in fresh fruits, beans, vegetables and grains, typical of the Mediterranean diet, are recommended against Cd-induced testicular injury.

Graphical Abstract

1. Cadmium: The Beginning of History in Humans

In agriculture and industry, a large quantity of pesticides and chemicals, necessary for the increase in the economic yield of soil and the production of electronic devices, vehicles, paints and other materials, are released into the environment [1,2].
Regarding the heavy metals, some (iron (Fe), cobalt, copper (Cu), manganese, zinc (Zn), and molybdenum) are essential at low concentrations for metabolic activity [3]. Other, in particular, mercury (Hg), cadmium (Cd), nickel (Ni), arsenic and lead (Pb), are not biodegradable and have a long biological half-life [4]; thus, they accumulate in the environment and are then absorbed by the human body. As they have no identified useful biological function, they are considered as “toxic heavy metals” (THM) [5].
Once in the body, THM affect different physiological processes, even at very low concentrations [6], as they are used as a substitute of essential elements: Pb can take the place of calcium and Cd the place of Zn [7]. As a result, they can cause numerous diseases, such as kidney toxicity [8], impaired lung function [9], neurotoxic effects [10,11], hormonal imbalance [12], abnormal spermatogenesis and infertility [13], and even cancer [14,15,16]. Furthermore, THM can cross the placenta and interfere with fetal developmental processes [17].
Among THM, Cd is a major heavy metal toxic to the environment that causes harmful events in many biological processes of humans, animals and plants [18]. Cd is a physically soft metal, not biodegradable, and with a half-life of 15–30 years in humans [13]. In the industry, it has a wide range of applications owing to its outstanding characteristics against corrosion and resistance to oxidation: in fact, it is used in the construction of Ni-Cd batteries, in the production of many materials as color element, in the coating of mechanical parts and in photography [18]. Among the different compounds, only a small part (1–10%) of the orally ingested dose of cadmium chloride (CdCl2) is absorbed through the intestine [19,20]; instead, cadmium oxide (CdO) is absorbed through respiration.
In humans, Cd exposure is mainly due to cigarette smoke, as it is accumulated in tobacco plants with a concentration ranging from 650 to 3630 ng/g tobacco [21]. From the cigarette smoke 50–100% of the small particles of Cd are absorbed from the alveolar epithelium, pass through the pulmonary interstitial tissue and enter the circulation [22]. Environmental respiratory intake is particularly important in workers of mines, and paint and battery factories, where dust and fumes may contain significant amounts of Cd. Then, toxicants, once passed the upper airways protection structures and entered into the alveoli, are absorbed and transferred in the blood [23].
In nonsmokers, Cd exposure is usually linked to food intake, with different degrees of absorption based on the type of the toxicant, its dose and the frequency of exposure [24]. The efficiency of Cd absorption from the gastro-intestinal tract is low; in humans the uptake is about 3–7% [25]. As to the levels of Cd consumed with food, daily human intakes range from 10 μg Cd/kg body weight, considered as high exposure, to 0.1 μg/kg, but should not exceed 21.4 μg [26]. As a matter of fact, some discrepancies are present in different countries, related to the industrialization level, type of job and food habits of the local culture. In fact, in China, cereals were the most significant contributors to the dietary intake of Cd, whereas in France and Spain, the highest concentration of Cd was in fish and fish products [27]. In the USA, the food groups that contributed most to Cd intake were cereals and bread, followed by leafy vegetables and potatoes [28]. In Sicily, fish, vegetables and potatoes were particularly abundant in Cd levels [29,30].
Once in circulation, about 90% of Cd is bound to serum albumin and α2-macroglobulin [31]. In this way, Cd is carried to the liver, where the complex is degraded; as a result, metallothioneins (MT), small cysteine-rich proteins, are synthetized [32]. Even if the four main isoforms (MT-1 to MT-4) are known, the administration of heavy metals, such as Cd, causes the biosynthesis of MT-1 and MT-2 acting on specific transcriptional factors; on the contrary, no specific role in the detoxification of heavy metals is known for MT-3 and MT-4 [33]. MT-1 and MT-2 may bind both functional (Cu, Zn, Fe) and toxic (Cd, Hg, Ni, Pb) heavy metals through four thiol groups of cysteines. When bound to Cd, MTs are stored in hepatocytes as Cd-MT complexes, thus trying to protect the cells from toxic Cd ions. Even if large amounts of these complexes are accumulated in the liver, small quantities are discharged into the blood, filtered by the glomeruli and absorbed by renal tubular cells [34]. Once in the cells, the Cd-MT complex is degraded by lysosomes to amino acids and free Cd ions. Finally, when compared with other heavy metals, Cd shows low toxic effects to the fetus and the central nervous system [34].

2. Nutraceuticals: The New Frontier of Nutrition

The word nutraceutical, made from the terms “nutrient” and “pharmaceutical”, was coined by Stephen DeFelice in 1995, who defined nutraceuticals as “foods (or part of a food) that provide medical or health benefits, including the prevention and/or treatment of a disease” [35]. Currently, the term “nutraceutical” applies to a wide range of products, such as dietary supplements, herbal/botanical products, specific processed foods (functional foods) and also isolated nutrients. The terms “dietary supplements” and “functional foods” are used without distinction as synonyms, although there are substantial differences between them; we then classify: (i) “dietary supplements”, (ii) “functional foods” and (iii) “nutraceuticals” [36].
Many new nutraceuticals have been recently added and include phenolic compounds, organic acis, tocopherol, carotenoids, anthraquinones, terpenes, alkaloids, isothiocyanates and mono- and poly- unsaturated fatty acids, among others.
Indeed, consumers in different parts of world demonstrate great acceptance of these products because are particularly attracted by their plant origin, and also nutraceutical-producing companies, beyond the nutritional value, are strongly interested by the growing market value of nutraceuticals that represent, to date, a therapeutic alternative to pharmaceuticals [37].

3. Cadmium and Toxicity of Testis: Potential Molecular Targets of Nutraceuticals

In populations living in Cd-polluted environments, higher numbers of testicular cancer cases [38], reduced semen quality, even infertility [39] and delayed puberty with reduced testicular growth [29], were observed, although with differences in susceptibility referred to genetic polymorphism [38].
An important reduction in male fertility has been associated with occupational exposure to Cd [40], whereas varicocele and other reproductive disorders account for only 23% of damaged reproductive conditions [4]. As a consequence of Cd exposure, severe hemorrhage, edema, necrosis of Leydig cells and decreased testosterone concentrations in the plasma and testes, reduced junctions of germ cells in the seminiferous tubules and a loss of integral membrane proteins at the Sertoli cell interface of the blood–testis barrier (BTB), a reduction in the count and motility of sperm have been observed [41,42,43,44,45,46,47]. Furthermore, Cd is also classified as a potential human carcinogen by the International Agency for Research on Cancer [48]: in fact, Leydig cells death or even cancer were demonstrated [49].
Even if the causes of Cd-induced reproductive toxicity have been not yet fully elucidated [50], several mechanisms have been demonstrated, such as oxidative stress [34,51], DNA changes [52], apoptosis [53], inflammation [54], disruption of the BTB [45,46,55] and hormonal imbalance [44,56].
In experimental models, we used a single dose of CdCl2, that is 2 mg/kg/day, after having tested the effects of different doses able to induce testis damages [44]: this point deserves a specific discussion. In fact, this dosage is in accordance with previous studies on the topic [57,58] and was used to evaluate the toxicity of Cd without causing extensive and irreversible damages of the seminiferous epithelium. Different doses, either lower [59] or higher [60,61], different methods of administration, oral [62] or subcutaneous [63], and different durations of Cd administration [64] are able to induce structural changes in the male genital apparatus. In addition, it must be considered that exposure to heavy metals such as Cd is different from environmental conditions typical of polluted areas [29,56,65], where many substances can contribute to amplify the toxic action of Cd. In any case, the results obtained with a single dose of Cd allow us to attribute all biochemical and morphological changes observed in experimental conditions to Cd.
Specifically, in this context, our research lab and other groups tried to identify the putative pathophysiological mechanisms involved in Cd toxicity, such as oxidative stress, inflammation, apoptosis, hormonal imbalance, that, in turn, through an intriguing molecular crosstalk, are all able to induce severe BTB damage. Based on these findings, new possible therapeutic approaches involving the relationship between dietary strategies, use of nutraceuticals, nanostructures and nanotechnologies are recommended against Cd-induced testicular injury.
So far, recent evidence and the experience of our research lab suggested that nutraceuticals can be added easily and affordably to the daily diet and are expected to have very few side effects compared with chelation therapy. As a matter of fact, observational studies showed a positive association between sperm parameters and following a Mediterranean diet [66,67], possibly correlated to the antioxidant characteristic of the different nutrients typical of this dietary approach [68], able to positively impact on semen parameters [69,70,71]. Then, in human exposition to heavy metals, such as Cd, a coherent use of nutraceuticals may be a new reliable strategy, particularly in organs which are very susceptible to damage, such as testis, suggesting that the recent results reported in the present review could be translated in clinical practice (Figure 1). Then, in light of this background, we conducted a narrative review including experimental and clinical studies with the aim to better define the intriguing relationship between Cd, testis and nutraceuticals. Of course, we hope that, in upcoming years, through the development of knowledge about this controversial topic it will be possible to assess a more detailed systematic review with the main goal to estimate the effectiveness of nutraceutical intervention on Cd-induced testicular injury.

4. Cadmium-Induced Oxidative Stress Causes Testicular Injury and Represents an Attractive Molecular Target for Nutraceuticals

Oxidative stress is one of the main mechanisms of Cd-induced testicular damage [72]. In fact, Cd promotes the production of reactive oxygen species (ROS), inducing sperm DNA damage [73]. ROS are particularly important in Cd toxicology, either in vitro [74] or in vivo through all routes of exposure [75].
Under physiological conditions (oxidative eustress), ROS show positive effects, as they control several physiological responses [76]. In fact, ROS regulate the immune response and vital cellular functions, such as growth, differentiation and migration, control intercellular junctions, trigger different pathways, such as Nuclear Factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs), and modulate apoptosis [77].
Instead, an increased or persistent production of ROS induces harmful effects, leading to cell dysfunction or death. The mechanisms involved in Cd toxicity include the reduction in glutathione (GSH) and protein-bound sulfhydryl groups, causing an increased production of ROS, such as hydroxyl radicals, hydrogen peroxide and superoxide ions, able to induce lipid peroxidation [78]. It must be kept in mind that spermatozoa are extremely sensitive to ROS, owing to their high amount of polyunsaturated fatty acids and their low capacity to repair DNA [23,73]. As a result, a ROS increase is able to induce damage in the key enzymes involved in testicular steroidogenesis, with a reduction in testosterone levels [79], and in the process of spermatogenesis [80], with abnormal sperm morphology and decreased sperm number, finally inducing male infertility.
Oxidative stress seems to be crucial in the etiology of Cd-induced male reproductive toxicity in humans and animals. Thus, antioxidant therapy is considered an important approach for the intervention of Cd toxicity.
Alpha lipoic acid (ALA) is made naturally in the body and may protect against cell damage in different conditions. Spinach, broccoli and yeast are particularly rich in alpha lipoic acid. ALA, the “universal oxidant,” has been used for decades in Europe, especially Germany, to treat nerve conditions, including nerve damage resulting from poorly controlled diabetes [81]. The exogenous administration of ALA was shown to increase its free levels, thus lessening the oxidative stress both in vitro and in vivo [82]. Moreover, as ALA is able to chelate heavy metals such as Cd [83] when administered to rats chronically treated with Cd, it defends against testis lesions induced by increased levels of ROS, reestablishing the antioxidant status, normalizing steroidogenesis and reducing Cd increase [83].
Hesperetin, a Citrus flavonoid [84], exhibits antioxidant, anti-inflammatory and metal chelating activities. In vitro studies showed a potent radical scavenger role [85]. Accordingly, after the Cd challenge, the supplementation with hesperetin acted positively on the structure of seminiferous tubules, suggesting a protective role against increased ROS levels [86].
The flavonoid quercetin is able to attenuate the toxicity of environmental Cd on reproduction, through a reduction in ROS [87], by restoring the GSH level and enzymatic antioxidant endogenous system (superoxide dismutase (SOD) and GSH-Peroxidase).
Flavocoxid, a flavonoid containing both baicalin and catechin, with antibacterial, antiviral and anticancer properties [44,88], and positive cardiovascular effects [89], protected testis from Cd-induced damage, owing to its direct antioxidant activity, preventing the experimental generation of malondialdehyde (MDA).
In recent years, the analysis of phytomelatonin from several plant species has opened the door to its use as a nutraceutical compound, due to its outstanding actions at the cellular and physiological levels, especially its protective effect in plants exposed to diverse stress situations. Structurally, melatonin and phytomelatonin are the same molecule. Specifically, melatonin is the term first proposed in 2004, and refers to melatonin of plant origin [90]. Several studies have reported on detection of phytomelatonin in a variety of vegetables, fruits, seeds and medicinal herbs, and also in wild plants [91]. To date, the phytomelatonin content of coffee beans is the highest recorded in plant material. Moreover, apple and cherry, Goji berry, tomato and pepper fruits also showed a high phytomelatonin content. Overall, aromatic and medicinal plants had higher levels of phytomelatonin than seeds and fleshy fruits, whereas leaves, stems, seedlings and roots presented higher phytomelatonin content than fruits [80]. Consequently, botanical herbs are optimal candidates for use in the future, including the aim to counteract Cd-induced damage in testes. Melatonin pretreatment significantly lowered Cd toxic effects by inhibiting MDA levels, normalizing GSH and SOD activities, and decreasing the tumor necrosis factor (TNF)-α and interleukin (IL)-1β levels [92], thus protecting against Cd-induced testicular toxicity.
An important role in normal testicular development, spermatogenesis and spermatozoa motility is experimentally played by selenium (Se) in vivo and in humans [93]. Regarding the mechanism involved, Se is an important component of selenoproteins, such as GSH-Px and thioredoxin reductases [94,95]. Moreover, Se might also increase testosterone levels by stimulating synthetic enzyme activity [96].
Finally, among the natural nutraceutical antioxidants, myo-inositol (MI) had a significant role in reducing oxidative stress, as demonstrated by the increased levels of SOD, catalase (CAT) and GSH in juvenile carp [97]. Laboratory studies demonstrated that Cd adversely affects adipose tissue physiopathology through several antioxidant mechanisms, thus contributing to increased insulin resistance and enhancing diabetes [98]; intriguingly, a supplementation with a combination of MI and d-chiroinositol is an effective and safe strategy for improving glycemic control in type 2 diabetes [99,100,101].
We recently demonstrated the protective effect of MI, a minor role of Se and an evident positive role of the association between MI and Se on Cd-induced damages to the testes [46]. MI alone or associated with Se might protect the testes in subjects exposed to toxicants, at least to those with behavior similar to Cd.

5. Cadmium Toxicity: Inflammation Is a Significant Molecular Pathway Targeted by Nutraceuticals

Current literature showed that persistent oxidative stress can induce an amplification of inflammation, which is considered a significant pathological pathway in the testis after Cd challenge [54].
A central role in this process is played by cytokines able to control many testicular physiological functions, among which spermatogenesis, hormonal synthesis by Leydig cells, and regulation of the extratubular compartment are included. TNF-α is a crucial cytokine produced by Sertoli and germ cells in the testis; it strengthens and protracts the inflammatory response stimulating the release of cytokines and mediators. In addition to TNF-α, Cd exposure is able to cause an increased concentration of IL-1β, IL-6, IL-10, inducible Nitric Oxide Synthase (iNOS), Nitric Oxide (NO), Cyclooxygenase (COX)-2 and interferon (IFN)-γ owing to the augmented oxidative stress, which can have negative effects on spermiogenesis, cause structural changes in Sertoli cells junctions and interfere with the adhesion of the germinal epithelium to the tubular basement membrane [62].
Another negative impact of Cd is the induction of the NOD-like receptor protein (NLRP) inflammasome. Many inflammasomes have been described [102]. The most fully characterized is the NLRP3 inflammasome because it answers to different chemical and physical stimuli, inducing many diseases when out of control [103]. Once activated, NLRP3 activates caspase-1, which in turn induces the activation of IL-1β and IL-18 from pro-IL-1β and pro-IL-18 [104].
After the Cd challenge, NF-κB is considered to be a detrimental trigger in an inflammatory cascade in the testis. Under normal physiological conditions, NF-κB is bound to its inhibitory subunit, IkB, in the cytoplasm. After negative stimuli, it grows free from its subunit, migrates into the nucleus and induces the transcription of pro-inflammatory genes [105].
Cd-induced testis inflammation resulted in widespread necrosis and vacuolization of the seminiferous epithelium cells, together with interstitial tissue edema and hemorrhage, which was able to induce male infertility [23].
In this regard, it has also been shown that melatonin has an anti-inflammatory effect and suppresses the synthesis of pro-inflammatory cytokines [92].
Additionally, nutraceutical flavocoxid exerts important anti-inflammatory activity, inhibiting COX-2 and 5-Lipoxygenase (LOX), and reducing the synthesis of Prostaglandin (PGE)2 and Leukotriene (LT) B4 [106].
Recently, bergamot juice (BJ) has gained growing scientific interest [107,108]. In fact, it has been shown that BJ and its flavonoid-rich fraction (BJe) exert hypolipemic and hypoglycemic activity [109], anticancer [110], anti-infective [111], neuroprotective [112], antioxidant [113] and anti-inflammatory effects [114]. Our research lab recently confirmed the antioxidant effect of BJe, alone, or in combination with curcumin (Cur) and resveratrol (Re) against Cd-induced testicular injury, and we suggested that the bioactive compounds present in the phytocomplex can act in a multitarget mode of action [47].
Adenosine receptors were demonstrated to be a striking target in the management of healing disorders [115,116,117]. In fact, the inflammatory cascade is blocked by A2A receptor activation, thus ameliorating tissue repair and the healing process. In previous papers, we demonstrated the positive role of an A2A receptor agonist, polydeoxyribonucleotide (PDRN), a biologic drug obtained from the gonads of trout and containing different polynucleotides, in reducing inflammation and improving tissue repair [118,119,120,121]. In fact, when PDRN was administered to Cd-challenged mice, it lowered phosphorylated extracellular signal-regulated kinase (pERK) 1/2 expression, indicating the possibility that mitogen-activated protein (MAP) kinase could represent a trustworthy molecular target for nutraceuticals.
Accordingly, our research lab indicated that MI alone or associated with Se significantly reduced iNOS and TNF-α expression, indicating the significance of molecular crosstalk between oxidative stress and inflammatory cascades in the pathophysiology of Cd-induced testis damage [46].

6. Nutraceuticals and Cadmium-Induced Apoptosis in Testis

Oxidative stress and inflammation are also able to induce apoptosis in vitro [122] and in vivo [123].
Apoptosis is a programmed cell death able to cause different biochemical and morphological events, such as DNA fragmentation, chromatin condensation, cell shrinkage, membrane blebbing and the appearance of apoptotic bodies [4]. In the seminiferous tubules, during the normal process of spermatogenesis, apoptotic cellular death is crucial in its regulation to maintain the fertility potential of males [124].
In testicular germ cells of Cd-challenged animals, a trigger of apoptosis was observed via the endoplasmic reticulum stress-mediated apoptotic pathway, involving caspase-12 activation [125]. Apoptosis can also be induced via the mitochondrial pathway in germ cells with up-regulation of bcl-2-associated-X-protein (Bax), and down-regulation of B-cell lymphoma 2 (Bcl-2) genes. Although Bcl-2 inhibits apoptosis linking to the proapoptotic effector proteins [126], Bax modulates mitochondrial outer membrane permeabilization, thus causing apoptosis [53] and an increase in caspase-3 and -7. In fact, caspase-3 was demonstrated to be significantly high after 36 hours of exposure to Cd-treated rats, as also shown by Fouad et al. [58]. Instead, no significant variation of caspase 7 was observed [127].
Furthermore, a large number of TUNEL-positive germ cells, an increased level of Bax and a reduced level of Bcl-2 were observed in mice testes, thus confirming a negative role of CdCl2 on the seminiferous epithelium [44,47].
Therefore, these studies represent the complexity of different apoptotic pathways through which Cd induces apoptosis of testicular germ cells in different species that will help us in elucidating a common mechanism of apoptotic induction by Cd in testes [4].
Quercetin prevents apoptosis by modulating the expression of Bax, Bcl-extra-large (xL) and caspase-3 in germ cells [123]. similar results were obtained in Cd challenged rats protected with a grape seed proanthocyanidin extract (GSPE) [128]. Additionally, flavocoxid showed a similar activity against testicular damage induced by Cd [44].
Accordingly, we recently showed that BJe experimentally reduced apoptotic markers, thus protecting mice from Cd-induced testicular injury [47].
When rats exposed to Cd were treated with Cur, a phenolic compound obtained from Curcuma longa L. and largely used in traditional Asian medicine, reduced apoptosis, improved tubular morphology and testosterone levels were demonstrated [63].
Finally, our research lab experimentally investigated the protective and therapeutic effects of Re against CdCl2-induced toxicity in rat testes [46]. Indeed, Re showed a protective action against Cd testicular toxicity as it upregulated Bcl2 and downregulated p53 and Bax gene expression. Accordingly, a good improvement of functional and histopathological indicators was observed in the Re-pretreated mice [129].

7. Positive Effects of Nutraceuticals against Cadmium-Induced Testicular Injury on Blood–Testis Barrier Changes and Hormonal Imbalance

The BTB is formed by Sertoli cells by means of tight junctions [55]. In this way, the seminiferous epithelium is divided into a basal and an apical compartment, functionally and structurally different. A normal BTB is necessary to separate aploid germ cells from the immune system, and to prevent cytotoxic substances from passing from the circulation to the seminiferous epithelium [130]. When the BTB is damaged, germ cell loss and a reduced number of sperm occur with consequent subfertility or even infertility. After Cd challenge, BTB integrity is lost, owing to an evident increase in transforming growth factor (TGF)-β3, the most abundant form of TGF-β in the testis, produced by Sertoli cells, spermatogonia and early spermatocytes. TGF-β3 induces harmful effects in the tight junctions of Sertoli cells, owing to a decreased content in occludin, zonula occludens (ZO)-1, N-cadherin and claudin-11 [44,45,46,50]. In vitro studies showed that a correlation existed between tightness of the junctions and testosterone concentration [131].
In the testis, testosterone is required for the attachment of germ cells into the seminiferous tubules [132], and for the regular development of sperm cells [49]. Cd, besides causing a direct damage of the Leydig cells [46], is able to impair the hypothalamic-pituitary-gonadal axis [133], as demonstrated by the increased levels of follicle-stimulating hormone and luteinizing hormone, and by the decreased testosterone and inhibin-B serum levels [44].
We recently demonstrated that in mice treated with CdCl2, plus BJe alone or with associations with Cur-Re at different dosages, the seminiferous tubules had normal diameter and Johnsen’s scores, and the germinal epithelium showed mature spermatozoa [47].
Accordingly, in Cd-challenged mice, PDRN administration protected BTB ultrastructure, decreasing TGF-β3 immunoreactivity and enhancing its tight and adherens junctions [45].
Finally, MI alone or associated with Se significantly increased testosterone levels, ameliorated structural organization and increased the number of claudin-11 patches [46].

8. Conclusions

Cd is a highly diffused heavy metal and thus a ubiquitous environmental toxicant. The molecular mechanisms of Cd-induced structural and functional damages of the testicular tissue are a research topic of current interest. Dietary strategies and the use of nutraceuticals, especially, are recommended against Cd-induced testicular injury. Intriguingly, many studies indicate that the largest number of nutraceuticals has been found in foods typical of Mediterranean-style eating patterns, such as fresh fruits, beans, vegetables, grains and nuts [134,135,136]. Consequently, the addition in the diet of these compounds can be considered a new trustworthy medical tactic in subjects exposed to heavy metals, in particular to those whose mechanisms of action are similar to Cd (Table 1). Accordingly, a multifaceted mechanism of action by nutraceuticals appears crucial to counteract the detrimental molecular cascade in testicular injury caused by environmental heavy metals as Cd. Of course, we hope that the present narrative review, despite the limitations related to the type of review and lack of clinical data available to date, can be useful in improving the quality of life as well as environmental and food sustainability around the globe.

Author Contributions

Conceptualization, H.R.M., A.M., P.A. and L.M.; Data Curation, D.P., J.F. and P.A.; Writing— Original Draft, H.R.M., D.P. and L.M..; Writing—Review and Editing, H.R.M., A.M., G.S., D.P., J.F. and L.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets generated for this study are available on request to the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Fenner, K.; Canonica, S.; Wackett, L.P.; Elsner, M. Evaluating pesticide degradation in the environment: Blind spots and emerging opportunities. Science 2013, 341, 752–758. [Google Scholar] [CrossRef] [Green Version]
  2. Ajiboye, T.O.; Oyewo, O.A.; Onwudiwe, D.C. Simultaneous removal of organics and heavy metals from industrial wastewater: A review. Chemosphere 2021, 262, 128379. [Google Scholar] [CrossRef]
  3. Peralta-Videa, J.R.; Lopez, M.L.; Narayan, M.; Saupe, G.; Gardea-Torresdey, J. The biochemistry of environmental heavy metal uptake by plants: Implications for the food chain. Int. J. Biochem. Cell. Biol. 2009, 41, 1665–1677. [Google Scholar] [CrossRef]
  4. Bhardwaj, J.K.; Panchal, H.; Saraf, P. Cadmium as a testicular toxicant: A Review. J. Appl. Toxicol. 2021, 41, 105–117. [Google Scholar] [CrossRef]
  5. Clemens, S.; Ma, J.F. Toxic Heavy Metal and Metalloid Accumulation in Crop Plants and Foods. Annu. Rev. Plant Biol. 2016, 67, 489–512. [Google Scholar] [CrossRef] [Green Version]
  6. Manfo, F.P.; Moundipa, P.F.; Déchaud, H.; Tchana, A.N.; Nantia, E.A.; Zabot, M.T.; Pugeat, M. Effect of agropesticides use on male reproductive function: A study on farmers in Djutitsa (Cameroon). Environ. Toxicol. 2012, 27, 423–432. [Google Scholar] [CrossRef]
  7. Rehman, K.; Fatima, F.; Waheed, I.; Akash, M.S.H. Prevalence of exposure of heavy metals and their impact on health consequences. J. Cell. Biochem. 2018, 119, 157–184. [Google Scholar] [CrossRef]
  8. Lentini, P.; Zanoli, L.; Granata, A.; Signorelli, S.S.; Castellino, P.; Dell’Aquila, R. Kidney and heavy metals—The role of environmental exposure (Review). Mol. Med. Rep. 2017, 15, 3413–3419. [Google Scholar] [CrossRef] [Green Version]
  9. Hariri, A.; Mohamad Noor, N.; Paiman, N.A.; Ahmad Zaidi, A.M.; Zainal Bakri, S.F. Heavy metals found in the breathing zone, toenails and lung function of welders working in an air-conditioned welding workplace. Int. J. Occup. Saf. Ergon. 2018, 24, 646–651. [Google Scholar] [CrossRef]
  10. Carocci, A.; Rovito, N.; Sinicropi, M.S.; Genchi, G. Mercury toxicity and neurodegenerative effects. Rev. Environ. Contam. Toxicol. 2014, 229, 1–18. [Google Scholar] [CrossRef]
  11. Karri, V.; Schuhmacher, M.; Kumar, V. Heavy metals (Pb, Cd, As and MeHg) as risk factors for cognitive dysfunction: A general review of metal mixture mechanism in brain. Environ. Toxicol. Pharmacol. 2016, 48, 203–213. [Google Scholar] [CrossRef] [Green Version]
  12. Rana, S.V. Perspectives in endocrine toxicity of heavy metals—A review. Biol. Trace Elem. Res. 2014, 160, 1–14. [Google Scholar] [CrossRef]
  13. Bhardwaj, J.K.; Paliwal, A.; Saraf, P. Effects of heavy metals on reproduction owing to infertility. J. Biochem. Mol. Toxicol. 2021, 35, e22823. [Google Scholar] [CrossRef]
  14. Cole, P.; Rodu, B. Epidemiologic studies of chrome and cancer mortality: A series of meta-analyses. Regul. Toxicol. Pharmacol. 2005, 43, 225–231. [Google Scholar] [CrossRef]
  15. Tapio, S.; Grosche, B. Arsenic in the aetiology of cancer. Mutat. Res. 2006, 612, 215–246. [Google Scholar] [CrossRef]
  16. Lim, J.T.; Tan, Y.Q.; Valeri, L.; Lee, J.; Geok, P.P.; Chia, S.E.; Ong, C.N.; Seow, W.J. Association between serum heavy metals and prostate cancer risk—A multiple metal analysis. Environ. Int. 2019, 132, 105109. [Google Scholar] [CrossRef]
  17. Rahman, Z.; Singh, V.P. The relative impact of toxic heavy metals (THMs) (arsenic (As), cadmium (Cd), chromium (Cr)(VI), mercury (Hg), and lead (Pb)) on the total environment: An overview. Environ. Monit. Assess. 2019, 191, 419. [Google Scholar] [CrossRef]
  18. Unsal, V.; Dalkıran, T.; Çiçek, M.; Kölükçü, E. The Role of Natural Antioxidants Against Reactive Oxygen Species Produced by Cadmium Toxicity: A Review. Adv. Pharm. Bull. 2020, 10, 184–202. [Google Scholar] [CrossRef] [Green Version]
  19. Satarug, S.; Garrett, S.H.; Sens, M.A.; Sens, D.A. Cadmium, environmental exposure, and health outcomes. Environ. Health Perspect. 2010, 118, 182–190. [Google Scholar] [CrossRef]
  20. Fujiwara, Y.; Lee, J.Y.; Banno, H.; Imai, S.; Tokumoto, M.; Hasegawa, T.; Seko, Y.; Nagase, H.; Satoh, M. Cadmium induces iron deficiency anemia through the suppression of iron transport in the duodenum. Toxicol. Lett. 2020, 332, 130–139. [Google Scholar] [CrossRef]
  21. Piadé, J.; Jaccard, G.; Dolka, C.; Belushkin, M.; Wajrock, S. Differences in cadmium transfer from tobacco to cigarette smoke, compared to arsenic or lead. Toxicol. Rep. 2014, 2, 12–26. [Google Scholar] [CrossRef] [Green Version]
  22. Richter, P.; Faroon, O.; Pappas, R.S. Cadmium and Cadmium/Zinc Ratios and Tobacco-Related Morbidities. Int. J. Environ. Res. Public Health 2017, 14, 1154. [Google Scholar] [CrossRef] [Green Version]
  23. Rinaldi, M.; Micali, A.; Marini, H.; Adamo, E.B.; Puzzolo, D.; Pisani, A.; Trichilo, V.; Altavilla, D.; Squadrito, F.; Minutoli, L. Cadmium, Organ Toxicity and Therapeutic Approaches: A Review on Brain, Kidney and Testis Damage. Curr. Med. Chem. 2017, 24, 3879–3893. [Google Scholar] [CrossRef]
  24. Thévenod, F.; Lee, W.K. Toxicology of cadmium and its damage to mammalian organs. Met. Ions Life Sci. 2013, 11, 415–490. [Google Scholar] [CrossRef]
  25. Brzóska, M.M.; Moniuszko-Jakoniuk, J. The influence of calcium content in diet on cumulation and toxicity of cadmium in the organism. Arch. Toxicol. 1998, 72, 63–73. [Google Scholar] [CrossRef]
  26. Koch, W.; Karim, M.R.; Marzec, Z.; Miyataka, H.; Himeno, S.; Asakawa, Y. Dietary intake of metals by the young adult population of Eastern Poland: Results from a market basket study. J. Trace Elem. Med. Biol. 2016, 35, 36–42. [Google Scholar] [CrossRef]
  27. Yu, G.; Zheng, W.; Wang, W.; Dai, F.; Zhang, Z.; Yuan, Y.; Wang, Q. Health risk assessment of Chinese consumers to Cadmium via dietary intake. J. Trace Elem. Med. Biol. 2017, 44, 137–145. [Google Scholar] [CrossRef]
  28. Kim, K.; Melough, M.M.; Vance, T.M.; Noh, H.; Koo, S.I.; Chun, O.K. Dietary Cadmium Intake and Sources in the US. Nutrients 2018, 1, 2. [Google Scholar] [CrossRef] [Green Version]
  29. Interdonato, M.; Bitto, A.; Pizzino, G.; Irrera, N.; Pallio, G.; Mecchio, A.; Cuspilici, A.; Minutoli, L.; Altavilla, D.; Squadrito, F. Levels of heavy metals in adolescents living in the industrialised area of Milazzo-Valle del Mela (northern Sicily). J. Environ. Public. Health 2014, 2014, 326845. [Google Scholar] [CrossRef]
  30. Copat, C.; Bella, F.; Castaing, M.; Fallico, R.; Sciacca, S.; Ferrante, M. Heavy metals concentrations in fish from Sicily (Mediterranean Sea) and evaluation of possible health risks to consumers. Bull. Environ. Contam. Toxicol. 2012, 88, 78–83. [Google Scholar] [CrossRef] [Green Version]
  31. Liu, Y.; Chen, M.; Jiang, L.; Song, L. New insight into molecular interaction of heavy metal pollutant--cadmium(II) with human serum albumin. Environ. Sci. Pollut. Res. Int. 2014, 21, 6994–7005. [Google Scholar] [CrossRef] [PubMed]
  32. Sabolić, I.; Breljak, D.; Skarica, M.; Herak-Kramberger, C.M. Role of metallothionein in cadmium traffic and toxicity in kidneys and other mammalian organs. Biometals 2010, 23, 897–926. [Google Scholar] [CrossRef] [PubMed]
  33. Babula, P.; Masarik, M.; Adam, V.; Eckschlager, T.; Stiborova, M.; Trnkova, L.; Skutkova, H.; Provaznik, I.; Hubalek, J.; Kizek, R. Mammalian metallothioneins: Properties and functions. Metallomics 2012, 4, 739–750. [Google Scholar] [CrossRef]
  34. Genchi, G.; Sinicropi, M.S.; Lauria, G.; Carocci, A.; Catalano, A. The Effects of Cadmium Toxicity. Int. J. Environ. Res. Public Health 2020, 17, 3782. [Google Scholar] [CrossRef]
  35. DeFelice, S.L. The nutraceutical revolution: Its impact on food industry R&D. Trends Food Sci. Technol. 1995, 6, 59–61. [Google Scholar]
  36. Singh, J.; Sinha, S. Classification, Regulatory Acts and Applications of Nutraceuticals for Health. Int. J. Pharma. Biosci. 2012, 2, 177–187. [Google Scholar]
  37. Nasri, H.; Baradaran, A.; Shirzad, H.; Kopaei, M.R. New concepts in nutraceuticals as alternative for pharmaceuticals. Int. J. Prev. Med. 2014, 5, 1487–1499. [Google Scholar]
  38. Pizent, A.; Tariba, B.; Živković, T. Reproductive toxicity of metals in men. Arh. Hig. Rada. Toksikol. 2012, 63 (Suppl. 1), 35–46. [Google Scholar] [CrossRef]
  39. Benoff, S.; Hauser, R.; Marmar, J.L.; Hurley, I.R.; Napolitano, B.; Centola, G.M. Cadmium concentrations in blood and seminal plasma: Correlations with sperm number and motility in three male populations (infertility patients, artificial insemination donors, and unselected volunteers). Mol. Med. 2009, 15, 248–262. [Google Scholar] [CrossRef]
  40. Telisman, S.; Cvitković, P.; Jurasović, J.; Pizent, A.; Gavella, M.; Rocić, B. Semen quality and reproductive endocrine function in relation to biomarkers of lead, cadmium, zinc, and copper in men. Environ. Health Perspect. 2000, 108, 45–53. [Google Scholar] [CrossRef]
  41. Monsefi, M.; Alaee, S.; Moradshahi, A.; Rohani, L. Cadmium-induced infertility in male mice. Environ. Toxicol. 2010, 25, 94–102. [Google Scholar] [CrossRef]
  42. Yari, A.; Asadi, M.H.; Bahadoran, H.; Dashtnavard, H.; Imani, H.; Naghii, M.R. Cadmium toxicity in spermatogenesis and protective effects of L-carnitine in adult male rats. Biol. Trace Elem. Res. 2010, 137, 216–225. [Google Scholar] [CrossRef]
  43. Marettová, E.; Maretta, M.; Legáth, J. Changes in the peritubular tissue of rat testis after cadmium treatment. Biol. Trace Elem. Res. 2010, 134, 288–295. [Google Scholar] [CrossRef] [PubMed]
  44. Minutoli, L.; Micali, A.; Pisani, A.; Puzzolo, D.; Bitto, A.; Rinaldi, M.; Pizzino, G.; Irrera, N.; Galfo, F.; Arena, S.; et al. Flavocoxid Protects Against Cadmium-Induced Disruption of the Blood–Testis Barrier and Improves Testicular Damage and Germ Cell Impairment in Mice. Toxicol. Sci. 2015, 148, 311–329. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Squadrito, F.; Micali, A.; Rinaldi, M.; Irrera, N.; Marini, H.; Puzzolo, D.; Pisani, A.; Lorenzini, C.; Valenti, A.; Laurà, R.; et al. Polydeoxyribonucleotide, an Adenosine-A2A Receptor Agonist, Preserves Blood Testis Barrier from Cadmium-Induced Injury. Front. Pharmacol. 2017, 7, 537. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Benvenga, S.; Micali, A.; Pallio, G.; Vita, R.; Malta, C.; Puzzolo, D.; Irrera, N.; Squadrito, F.; Altavilla, D.; Minutoli, L. Effects of Myo-inositol Alone and in Combination with Seleno-Lmethionine on Cadmium-Induced Testicular Damage in Mice. Curr. Mol. Pharmacol. 2019, 12, 311–323. [Google Scholar] [CrossRef]
  47. Ferlazzo, N.; Micali, A.; Marini, H.R.; Freni, J.; Santoro, G.; Puzzolo, D.; Squadrito, F.; Pallio, G.; Navarra, M.; Cirmi, S.; et al. A Flavonoid-Rich Extract from Bergamot Juice, Alone or in Association with Curcumin and Resveratrol, Shows Protective Effects in a Murine Model of Cadmium-Induced Testicular Injury. Pharmaceuticals 2021, 14, 386. [Google Scholar] [CrossRef]
  48. IARC. Cadmium and cadmium compounds. IARC Monogr. Eval. Carcinog. Risks Hum. 1993, 58, 119–237. [Google Scholar]
  49. Zhu, Q.; Li, X.; Ge, R.S. Toxicological Effects of Cadmium on Mammalian Testis. Front. Genet. 2020, 11, 527. [Google Scholar] [CrossRef]
  50. Anyanwu, B.O.; Orisakwe, O.E. Current mechanistic perspectives on male reproductive toxicity induced by heavy metals. J. Environ. Sci. Health C Toxicol. Carcinog. 2020, 38, 204–244. [Google Scholar] [CrossRef]
  51. Fu, Z.; Xi, S. The effects of heavy metals on human metabolism. Toxicol. Mech. Methods 2020, 30, 167–176. [Google Scholar] [CrossRef] [PubMed]
  52. Oliveira, H.; Lopes, T.; Almeida, T.; Pereira Mde, L.; Santos, C. Cadmium-induced genetic instability in mice testis. Hum. Exp. Toxicol. 2012, 31, 1228–1236. [Google Scholar] [CrossRef] [PubMed]
  53. Amanpour, P.; Khodarahmi, P.; Salehipour, M. Protective effects of vitamin E on cadmium-induced apoptosis in rat testes. Naunyn Schmiedebergs Arch. Pharmacol. 2020, 393, 349–358. [Google Scholar] [CrossRef]
  54. Yu, W.; Xu, Z.; Gao, Q.; Xu, Y.; Wang, B.; Dai, Y. Protective role of wogonin against cadmium induced testicular toxicity: Involvement of antioxidant, anti-inflammatory and anti-apoptotic pathways. Life Sci. 2020, 258, 118192. [Google Scholar] [CrossRef]
  55. de Angelis, C.; Galdiero, M.; Pivonello, C.; Salzano, C.; Gianfrilli, D.; Piscitelli, P.; Lenzi, A.; Colao, A.; Pivonello, R. The environment and male reproduction: The effect of cadmium exposure on reproductive function and its implication in fertility. Reprod. Toxicol. 2017, 73, 105–127. [Google Scholar] [CrossRef]
  56. Interdonato, M.; Pizzino, G.; Bitto, A.; Galfo, F.; Irrera, N.; Mecchio, A.; Pallio, G.; Ramistella, V.; De Luca, F.; Santamaria, A.; et al. Cadmium delays puberty onset and testis growth in adolescents. Clin. Endocrinol. (Oxf) 2015, 83, 357–362. [Google Scholar] [CrossRef]
  57. Mishra, R.K.; Jain, A.; Singh, S.K. Profertility effects of Shilajit on cadmium-induced infertility in male mice. Andrologia 2018, 50, e13064. [Google Scholar] [CrossRef]
  58. Fouad, A.A.; Qureshi, H.A.; Al-Sultan, A.I.; Yacoubi, M.T.; Ali, A.A. Protective effect of hemin against cadmium-induced testicular damage in rats. Toxicology 2009, 257, 153–160. [Google Scholar] [CrossRef]
  59. de Souza Predes, F.; Diamante, M.A.; Dolder, H. Testis response to low doses of cadmium in Wistar rats. Int. J. Exp. Pathol. 2010, 91, 125–131. [Google Scholar] [CrossRef]
  60. Miura, N.; Yanagiba, Y.; Ohtani, K.; Mita, M.; Togawa, M.; Hasegawa, T. Diurnal variation of cadmium-induced mortality in mice. J. Toxicol. Sci. 2012, 37, 191–196. [Google Scholar] [CrossRef] [Green Version]
  61. Ohtani, K.; Yanagiba, Y.; Ashimori, A.; Takeuchi, A.; Takada, N.; Togawa, M.; Hasegawa, T.; Ikeda, M.; Miura, N. Influence of injection timing on severity of cadmium-induced testicular toxicity in mice. J. Toxicol. Sci. 2013, 38, 145–150. [Google Scholar] [CrossRef] [Green Version]
  62. Bashir, N.; Shagirtha, K.; Manoharan, V.; Miltonprabu, S. The molecular and biochemical insight view of grape seed proanthocyanidins in ameliorating cadmium-induced testes-toxicity in rat model: Implication of PI3K/Akt/Nrf-2 signaling. Biosci. Rep. 2019, 39, BSR20180515. [Google Scholar] [CrossRef] [Green Version]
  63. Aktas, C.; Kanter, M.; Erboga, M.; Ozturk, S. Anti-apoptotic effects of curcumin on cadmium-induced apoptosis in rat testes. Toxicol. Ind. Health 2012, 28, 122–130. [Google Scholar] [CrossRef]
  64. Adamkovicova, M.; Toman, R.; Martiniakova, M.; Omelka, R.; Babosova, R.; Krajcovicova, V.; Grosskopf, B.; Massanyi, P. Sperm motility and morphology changes in rats exposed to cadmium and diazinon. Reprod. Biol. Endocrinol. 2016, 14, 42. [Google Scholar] [CrossRef] [Green Version]
  65. Hu, Y.; Wang, C.; Song, Z.; Chen, M.; Ding, L.; Liang, X.; Bi, X.; Li, Z.; Li, P.; Zheng, W. Heavy Metal in Rice and Vegetable and Human Exposure near a Large Pb/Zn Smelter in Central China. Int. J. Environ. Res. Public Health 2021, 18, 12631. [Google Scholar] [CrossRef] [PubMed]
  66. Salas-Huetos, A.; James, E.R.; Aston, K.I.; Jenkins, T.G.; Carrell, D.T. Diet and sperm quality: Nutrients, foods and dietary patterns. Reprod. Biol. 2019, 19, 219–224. [Google Scholar] [CrossRef] [PubMed]
  67. Efrat, M.; Stein, A.; Pinkas, H.; Unger, R.; Birk, R. Dietary patterns are positively associated with semen quality. Fertil. Steril. 2018, 109, 809–816. [Google Scholar] [CrossRef] [PubMed]
  68. Aitken, R.J. Oxidative stress and the etiology of male infertility. J. Assist. Reprod. Genet. 2016, 33, 1691–1692. [Google Scholar] [CrossRef] [Green Version]
  69. Torres-Arce, E.; Vizmanos, B.; Babio, N.; Marquez-Sandoval, F.; Salas-Huetos, A. Dietary Antioxidants in the Treatment of Male Infertility: Counteracting Oxidative Stress. Biology 2021, 10, 241. [Google Scholar] [CrossRef]
  70. Santoro, M.; Aquila, S.; Russo, G. Sperm performance in oligoasthenoteratozoospermic patients is induced by a nutraceuticals mix, containing mainly myo-inositol. Syst. Biol. Reprod. Med. 2021, 67, 50–63. [Google Scholar] [CrossRef]
  71. Delbarba, A.; Arrighi, N.; Facondo, P.; Cappelli, C.; Ferlin, A. Positive effect of nutraceuticals on sperm DNA damage in selected infertile patients with idiopathic high sperm DNA fragmentation. Minerva Endocrinol. 2020, 45, 89–96. [Google Scholar] [CrossRef] [PubMed]
  72. Siu, E.R.; Mruk, D.D.; Porto, C.S.; Cheng, C.Y. Cadmium-induced testicular injury. Toxicol. Appl. Pharmacol. 2009, 238, 240–249. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Barati, E.; Nikzad, H.; Karimian, M. Oxidative stress and male infertility: Current knowledge of pathophysiology and role of antioxidant therapy in disease management. Cell. Mol. Life Sci. 2020, 77, 93–113. [Google Scholar] [CrossRef]
  74. Ranganathan, P.; Rao, K.A.; Sudan, J.J.; Balasundaram, S. Cadmium effects on sperm morphology and semenogelin with relates to increased ROS in infertile smokers: An in vitro and in silico approach. Reprod. Biol. 2018, 18, 189–197. [Google Scholar] [CrossRef]
  75. Amara, S.; Abdelmelek, H.; Garrel, C.; Guiraud, P.; Douki, T.; Ravanat, J.L.; Favier, A.; Sakly, M.; Ben Rhouma, K. Preventive effect of zinc against cadmium-induced oxidative stress in the rat testis. J. Reprod. Dev. 2008, 54, 129–134. [Google Scholar] [CrossRef] [Green Version]
  76. Sies, H.; Jones, D.P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 2020, 21, 363–383. [Google Scholar] [CrossRef]
  77. Minutoli, L.; Puzzolo, D.; Rinaldi, M.; Irrera, N.; Marini, H.; Arcoraci, V.; Bitto, A.; Crea, G.; Pisani, A.; Squadrito, F.; et al. ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury. Oxid. Med. Cell. Longev. 2016, 2016, 2183026. [Google Scholar] [CrossRef]
  78. Liu, J.; Qu, W.; Kadiiska, M.B. Role of oxidative stress in cadmium toxicity and carcinogenesis. Toxicol. Appl. Pharmacol. 2009, 238, 209–214. [Google Scholar] [CrossRef] [Green Version]
  79. Han, C.; Zhu, Y.; Yang, Z.; Fu, S.; Zhang, W.; Liu, C. Protective effect of Polygonatum sibiricum against cadmium-induced testicular injury in mice through inhibiting oxidative stress and mitochondria-mediated apoptosis. J. Ethnopharmacol. 2020, 261, 113060. [Google Scholar] [CrossRef]
  80. Jamalan, M.; Ghaffari, M.A.; Hoseinzadeh, P.; Hashemitabar, M.; Zeinali, M. Human Sperm Quality and Metal Toxicants: Protective Effects of some Flavonoids on Male Reproductive Function. Int. J. Fertil. Steril. 2016, 10, 215–223. [Google Scholar] [CrossRef]
  81. Papanas, N.; Ziegler, D. Efficacy of α-lipoic acid in diabetic neuropathy. Expert Opin. Pharmacother. 2014, 15, 2721–2731. [Google Scholar] [CrossRef] [PubMed]
  82. Selvakumar, E.; Prahalathan, C.; Sudharsan, P.T.; Varalakshmi, P. Chemoprotective effect of lipoic acid against cyclophosphamide- induced changes in the rat sperm. Toxicology 2006, 217, 71–78. [Google Scholar] [CrossRef] [PubMed]
  83. El-Maraghy, S.A.; Nassar, N.N. Modulatory effects of lipoic acid and selenium against cadmium-induced biochemical alterations in testicular steroidogenesis. J. Biochem. Mol. Toxicol. 2011, 25, 15–25. [Google Scholar] [CrossRef] [PubMed]
  84. Ameer, B.; Weintraub, R.A.; Johnson, J.V.; Yost, R.A.; Rouseff, R.L. Flavanone absorption after naringin, hesperidin, and citrus administration. Clin. Pharmacol. Ther. 1996, 60, 34–40. [Google Scholar] [CrossRef]
  85. Kim, J.Y.; Jung, K.J.; Choi, J.S.; Chung, H.Y. Hesperetin: A potent antioxidant against peroxynitrite. Free Radic. Res. 2004, 38, 761–769. [Google Scholar] [CrossRef]
  86. Shagirtha, K.; Pari, L. Hesperitin, a citrus flavonone, protects potentially cadmium induced oxidative testicular dysfunctions in rats. Ecotoxicol. Environ. Saf. 2011, 74, 2105–2111. [Google Scholar] [CrossRef]
  87. Morales, A.I.; Vicente-Sanchez, C.; Egido, J.; Arevalo, M.A.; Lopeznovoa, J.M. Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties. Food Chem. Toxicol. 2006, 44, 2092–2100. [Google Scholar] [CrossRef]
  88. Altavilla, D.; Minutoli, L.; Polito, F.; Irrera, N.; Arena, S.; Magno, C.; Rinaldi, M.; Burnett, B.P.; Squadrito, F.; Bitto, A. Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia. Br. J. Pharmacol. 2012, 167, 95–108. [Google Scholar] [CrossRef] [Green Version]
  89. Huang, Y.; Tsang, S.Y.; Yao, X.; Chen, Z.Y. Biological properties of baicalein in cardiovascular system. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2005, 5, 177–184. [Google Scholar] [CrossRef]
  90. Blask, D.E.; Dauchy, R.T.; Sauer, L.A.; Krause, J.A. Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: Melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin. Carcinogenesis 2004, 25, 951–960. [Google Scholar] [CrossRef]
  91. Arnao, M.B.; Hernández-Ruiz, J. The Potential of Phytomelatonin as a Nutraceutical. Molecules 2018, 23, 238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  92. Li, R.; Luo, X.; Li, L.; Peng, Q.; Yang, Y.; Zhao, L.; Ma, M.; Hou, Z. The protective effects of melatonin against oxidative stress and inflammation induced by acute cadmium exposure in mice testis. Biol. Trace Elem. Res. 2016, 170, 152–164. [Google Scholar] [CrossRef] [PubMed]
  93. Messaoudi, I.; Banni, M.; Saïd, L.; Saïd, K.; Kerkeni, A. Involvement of selenoprotein P and GPx4 gene expression in cadmium-induced testicular pathophysiology in rat. Chem. Biol Interact. 2010, 188, 94–101. [Google Scholar] [CrossRef] [PubMed]
  94. Ursini, F.; Heim, S.; Kiess, M.; Maiorino, M.; Roveri, A.; Wissing, J.; Flohé, L. Dual function of the selenoprotein PHGPx during sperm maturation. Science 1999, 285, 1393–1396. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Ottaviano, F.G.; Tang, S.S.; Handy, D.E.; Loscalzo, J. Regulation of the extracellular antioxidant selenoprotein plasma glutathione peroxidase (GPx-3) in mammalian cells. Mol. Cell. Biochem. 2009, 327, 111–126. [Google Scholar] [CrossRef] [Green Version]
  96. Ren, X.M.; Wang, G.G.; Xu, D.Q.; Luo, K.; Liu, Y.X.; Zhong, Y.H.; Cai, Y.Q. The protection of selenium on cadmium-induced inhibition of spermatogenesis via activating testosterone synthesis in mice. Food Chem. Toxicol. 2012, 50, 3521–3529. [Google Scholar] [CrossRef]
  97. Jiang, W.D.; Wu, P.; Kuang, S.Y.; Liu, Y.; Jiang, J.; Hu, K.; Li, S.H.; Tang, L.; Feng, L.; Zhou, X.Q. Myo-inositol prevents copper-induced oxidative damage and changes in antioxidant capacity in various organs and the enterocytes of juvenile Jian carp (Cyprinus carpio var. Jian). Aquat. Toxicol. 2011, 105, 543–551. [Google Scholar] [CrossRef]
  98. Tinkov, A.A.; Filippini, T.; Ajsuvakova, O.P.; Aaseth, J.; Gluhcheva, Y.G.; Ivanova, J.M.; Bjørklund, G.; Skalnaya, M.G.; Gatiatulina, E.R.; Popova, E.V.; et al. The role of cadmium in obesity and diabetes. Sci. Total Environ. 2017, 601–602, 741–755. [Google Scholar] [CrossRef]
  99. Pintaudi, B.; Di Vieste, G.; Bonomo, M. The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes. Int. J. Endocrinol. 2016, 2016, 9132052. [Google Scholar] [CrossRef] [Green Version]
  100. Nayak, B.; Kondeti, V.K.; Xie, P.; Lin, S.; Viswakarma, N.; Raparia, K.; Kanwar, Y.S. Transcriptional and post-translational modulation of myo-inositol oxygenase by high glucose and related pathobiological stresses. J. Biol. Chem. 2011, 286, 27594–27611. [Google Scholar] [CrossRef] [Green Version]
  101. Muscogiuri, G.; Palomba, S.; Laganà, A.S.; Orio, F. Inositols in the Treatment of Insulin-Mediated Diseases. Int. J. Endocrinol. 2016, 2016, 3058393. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  102. Duéñez-Guzmán, E.A.; Haig, D. The evolution of reproduction-related NLRP genes. J. Mol. Evol. 2014, 78, 194–201. [Google Scholar] [CrossRef] [PubMed]
  103. Chen, S.; Sun, B. Negative regulation of NLRP3 inflammasome signaling. Protein Cell. 2013, 4, 251–258. [Google Scholar] [CrossRef] [Green Version]
  104. He, Y.; Hara, H.; Núñez, G. Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem. Sci. 2016, 41, 1012–1021. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Mitchell, S.; Vargas, J.; Hoffmann, A. Signaling via the NFκB system. Wiley Interdiscip. Rev. Syst. Biol. Med. 2016, 8, 227–241. [Google Scholar] [CrossRef] [Green Version]
  106. Burnett, B.P.; Levy, R.M. 5-Lipoxygenase metabolic contributions to NSAID-induced organ toxicity. Adv. Ther. 2012, 29, 79–98. [Google Scholar] [CrossRef] [Green Version]
  107. Cirmi, S.; Navarra, M.; Woodside, J.V.; Cantwell, M.M. Citrus fruits intake and oral cancer risk: A systematic review and meta-analysis. Pharmacol. Res. 2018, 133, 187–194. [Google Scholar] [CrossRef] [Green Version]
  108. Mannucci, C.; Navarra, M.; Calapai, F.; Squeri, R.; Gangemi, S.; Calapai, G. Clinical Pharmacology of Citrus bergamia: A Systematic Review. Phytother. Res. 2017, 31, 27–39. [Google Scholar] [CrossRef]
  109. Mollace, V.; Sacco, I.; Janda, E.; Malara, C.; Ventrice, D.; Colica, C.; Visalli, V.; Muscoli, S.; Ragusa, S.; Muscoli, C.; et al. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: From animal models to human studies. Fitoterapia 2011, 82, 309–316. [Google Scholar] [CrossRef]
  110. Navarra, M.; Femia, A.P.; Romagnoli, A.; Tortora, K.; Luceri, C.; Cirmi, S.; Ferlazzo, N.; Caderni, G. A flavonoid-rich extract from bergamot juice prevents carcinogenesis in a genetic model of colorectal cancer, the Pirc rat (F344/NTac-Apc(am1137)). Eur. J. Nutr. 2020, 59, 885–894. [Google Scholar] [CrossRef]
  111. Filocamo, A.; Bisignano, C.; Ferlazzo, N.; Cirmi, S.; Mandalari, G.; Navarra, M. In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori. BMC Complement. Altern. Med. 2015, 15, 256. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  112. Ferlazzo, N.; Cirmi, S.; Maugeri, A.; Russo, C.; Lombardo, G.E.; Gangemi, S.; Calapai, G.; Mollace, V.; Navarra, M. Neuroprotective Effect of Bergamot Juice in 6-OHDA-Induced SH-SY5Y Cell Death, an In Vitro Model of Parkinson’s Disease. Pharmaceutics 2020, 12, 326. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Fusco, R.; Cirmi, S.; Gugliandolo, E.; di Paola, R.; Cuzzocrea, S.; Navarra, M. A flavonoid-rich extract of orange juice reduced oxidative stress in an experimental model of inflammatory bowel disease. J. Funct. Foods 2017, 30, 168–178. [Google Scholar] [CrossRef]
  114. Musumeci, L.; Maugeri, A.; Cirmi, S.; Lombardo, G.E.; Russo, C.; Gangemi, S.; Calapai, G.; Navarra, M. Citrus fruits and their flavonoids in inflammatory bowel disease: An overview. Nat. Prod. Res. 2020, 34, 122–136. [Google Scholar] [CrossRef] [PubMed]
  115. Valls, M.D.; Cronstein, B.N.; Montesinos, M.C. Adenosine receptor agonists for promotion of dermal wound healing. Biochem. Pharmacol. 2009, 77, 1117–11124. [Google Scholar] [CrossRef] [Green Version]
  116. Montesinos, M.C.; Desai-Merchant, A.; Cronstein, B.N. Promotion of Wound Healing by an Agonist of Adenosine A2A Receptor Is Dependent on Tissue Plasminogen Activator. Inflammation 2015, 38, 2036–20341. [Google Scholar] [CrossRef]
  117. Guerrero, A. A2A Adenosine Receptor Agonists and their Potential Therapeutic Applications. An Update. Curr. Med. Chem. 2018, 25, 3597–3612. [Google Scholar] [CrossRef]
  118. Galeano, M.; Bitto, A.; Altavilla, D.; Minutoli, L.; Polito, F.; Calò, M.; Lo Cascio, P.; Stagno d’Alcontres, F.; Squadrito, F. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen. 2008, 16, 208–217. [Google Scholar] [CrossRef]
  119. Altavilla, D.; Bitto, A.; Polito, F.; Marini, H.; Minutoli, L.; Di Stefano, V.; Irrera, N.; Cattarini, G.; Squadrito, F. Polydeoxyribonucleotide (PDRN): A safe approach to induce therapeutic angiogenesis in peripheral artery occlusive disease and in diabetic foot ulcers. Cardiovasc. Hematol. Agents Med. Chem. 2009, 7, 313–321. [Google Scholar] [CrossRef]
  120. Koo, Y.; Yun, Y. Effects of polydeoxyribonucleotides (PDRN) on wound healing: Electric cell-substrate impedance sensing (ECIS). Mater. Sci. Eng. C Mater. Biol. Appl. 2016, 69, 554–560. [Google Scholar] [CrossRef]
  121. Jeong, W.; Yang, C.E.; Roh, T.S.; Kim, J.H.; Lee, J.H.; Lee, W.J. Scar Prevention and Enhanced Wound Healing Induced by Polydeoxyribonucleotide in a Rat Incisional Wound-Healing Model. Int. J. Mol. Sci. 2017, 18, 1698. [Google Scholar] [CrossRef] [PubMed]
  122. Angenard, G.; Muczynski, V.; Coffigny, H.; Pairault, C.; Duquenne, C.; Frydman, R.; Habert, R.; Rouiller-Fabre, V.; Livera, G. Cadmium increases human fetal germ cell apoptosis. Environ. Health Perspect. 2010, 118, 331–337. [Google Scholar] [CrossRef]
  123. Bu, T.; Mi, Y.; Zeng, W.; Zhang, C. Protective effect of quercetin on cadmium-induced oxidative toxicity on germ cells in male mice. Anat. Rec. 2011, 294, 520–526. [Google Scholar] [CrossRef] [PubMed]
  124. Aitken, R.J.; Findlay, J.K.; Hutt, K.J.; Kerr, J.B. Apoptosis in the germ line. Reproduction 2011, 141, 139–150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  125. Ji, Y.L.; Wang, H.; Zhang, C.; Zhang, Y.; Zhao, M.; Chen, Y.H.; Xu, D.X. N-acetylcysteine protects against cadmium-induced germ cell apoptosis by inhibiting endoplasmic reticulum stress in testes. Asian J. Androl. 2013, 15, 290–296. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  126. Iyer, S.; Uren, R.T.; Kluck, R.M. Probing BAK and BAX Activation and Pore Assembly with Cytochrome c Release, Limited Proteolysis, and Oxidant-Induced Linkage. Methods Mol. Biol. 2019, 1877, 201–216. [Google Scholar] [CrossRef]
  127. Wang, D.H.; Hu, J.R.; Wang, L.Y.; Hu, Y.J.; Tan, F.Q.; Zhou, H.; Shao, J.Z.; Yang, W.X. The apoptotic function analysis of p53, Apaf1, Caspase3 and Caspase7 during the spermatogenesis of the Chinese fire-bellied newt Cynops orientalis. PLoS ONE 2012, 7, e39920. [Google Scholar] [CrossRef]
  128. Sönmez, M.F.; Tascioglu, S. Protective effects of grape seed extract on cadmium-induced testicular damage, apoptosis, and endothelial nitric oxide synthases expression in rats. Toxicol. Ind. Health 2016, 32, 1486–1494. [Google Scholar] [CrossRef]
  129. Mitra, S.; Bhattacharyya, S.; Ray, S.; Saha, R.; Ghosh, P.; Rauth, S.; Mandal, S.; Banerjee, S.; Murmu, N. Resveratrol Alleviates Cadmium-Induced Damage and Overexpression of Epidermal Growth Factor Receptor and its Downstream Signaling Proteins in the Reproductive System of Male Swiss Albino Mice. J. Environ. Pathol. Toxicol. Oncol. 2016, 35, 73–90. [Google Scholar] [CrossRef]
  130. Cheng, C.Y.; Mruk, D.D. The blood-testis barrier and its implications for male contraception. Pharmacol. Rev. 2012, 64, 16–64. [Google Scholar] [CrossRef] [Green Version]
  131. Chung, N.P.; Cheng, C.Y. Is cadmium chloride-induced inter-sertoli tight junction permeability barrier disruption a suitable in vitro model to study the events of junction disassembly during spermatogenesis in the rat testis? Endocrinology 2001, 142, 1878–1888. [Google Scholar] [CrossRef] [PubMed]
  132. Habib, R.; Wahdan, S.A.; Gad, A.M.; Azab, S.S. Infliximab abrogates cadmium-induced testicular damage and spermiotoxicity via enhancement of steroidogenesis and suppression of inflammation and apoptosis mediators. Ecotoxicol. Environ. Saf. 2019, 182, 109398. [Google Scholar] [CrossRef] [PubMed]
  133. Lafuente, A. The hypothalamic-pituitary-gonadal axis is target of cadmium toxicity. An update of recent studies and potential therapeutic approaches. Food Chem. Toxicol. 2013, 59, 395–404. [Google Scholar] [CrossRef] [PubMed]
  134. Zamora-Ros, R.; Knaze, V.; Luján-Barroso, L.; Romieu, I.; Scalbert, A.; Slimani, N.; Hjartåker, A.; Engeset, D.; Skeie, G.; Overvad, K.; et al. Differences in dietary intakes, food sources and determinants of total flavonoids between Mediterranean and non-Mediterranean countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br. J. Nutr. 2013, 109, 1498–1507. [Google Scholar] [CrossRef]
  135. Russo, G.L.; Siani, A.; Fogliano, V.; Geleijnse, J.M.; Giacco, R.; Giampaoli, S.; Iacoviello, L.; Kromhout, D.; Lionetti, L.; Naska, A.; et al. The Mediterranean diet from past to future: Key concepts from the second "Ancel Keys" International Seminar. Nutr. Metab. Cardiovasc. Dis. 2021, 31, 717–732. [Google Scholar] [CrossRef] [PubMed]
  136. Montano, L.; Ceretti, E.; Donato, F.; Bergamo, P.; Zani, C.; Viola, G.C.V.; Notari, T.; Pappalardo, S.; Zani, D.; Ubaldi, S.; et al. Effects of a Lifestyle Change Intervention on Semen Quality in Healthy Young Men Living in Highly Polluted Areas in Italy: The FASt Randomized Controlled Trial. Eur. Urol. Focus 2021. [Google Scholar] [CrossRef]
Nutrients 14 00663 g001 550
Figure 1. Structure of the nutraceuticals that are proposed to be effective against Cd-induced testicular injury. It is interesting to observe that in the majority of chemical structures here reported, multiple hydroxyl groups that typically confer a greater antioxidant (radical scavenging) capacity are present. This biochemical feature could functionally help to reduce inflammation and apoptosis, and modulate hormonal imbalance in Cd-induced testicular injury.
Figure 1. Structure of the nutraceuticals that are proposed to be effective against Cd-induced testicular injury. It is interesting to observe that in the majority of chemical structures here reported, multiple hydroxyl groups that typically confer a greater antioxidant (radical scavenging) capacity are present. This biochemical feature could functionally help to reduce inflammation and apoptosis, and modulate hormonal imbalance in Cd-induced testicular injury.
Nutrients 14 00663 g001
Table
Table 1. Table indicating the role of various nutraceuticals against Cd-induced testicular injury, including compounds, food sources, mechanisms of action and specific references.
Table 1. Table indicating the role of various nutraceuticals against Cd-induced testicular injury, including compounds, food sources, mechanisms of action and specific references.
CompoundFood SourceMechanism of ActionReferences
α-lipoic acidSpinach, broccoliAO[81,82,83]
HesperidinCitrusAO–AI[84,86]
QuercetinRed apple, red onion, tomatoAO–AI[123]
FlavocoxidCathechin (green tea, dark chocolate) Baicalin (onions)AO–AI–AA–ABTBD[44]
Phyto-melatonineCoffe beans, apple, cherry, tomatoAO–AI[91]
Seleno-L-methyonineBrazilian nuts, potato, fishAO–AHI[93,94,96]
Myo-inositolCereals, citrus, dried plums, cantaloupe melonAO[46]
Bergamot juiceCitrus bergamia Risso et Poiteau (bergamot) fruitsAO–AI–AA[47,113]
PDRNTroutAO–AI–AA–ABTBD[45]
CurcuminCurcuma longaAO–AA[47,63]
ResveratrolRed wine, grape, peanuts, dried fruitAO–AI–AA–ABTBD[47]
AO = Antioxidant; AI = Anti-inflammatory; AA = Antiapoptotic; AHI = Antihormonal imbalance; ABTBD = Anti-blood–testis barrier damage.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Marini, H.R.; Micali, A.; Squadrito, G.; Puzzolo, D.; Freni, J.; Antonuccio, P.; Minutoli, L. Nutraceuticals: A New Challenge against Cadmium-Induced Testicular Injury. Nutrients 2022, 14, 663. https://doi.org/10.3390/nu14030663

AMA Style

Marini HR, Micali A, Squadrito G, Puzzolo D, Freni J, Antonuccio P, Minutoli L. Nutraceuticals: A New Challenge against Cadmium-Induced Testicular Injury. Nutrients. 2022; 14(3):663. https://doi.org/10.3390/nu14030663

Chicago/Turabian Style

Marini, Herbert Ryan, Antonio Micali, Giovanni Squadrito, Domenico Puzzolo, José Freni, Pietro Antonuccio, and Letteria Minutoli. 2022. "Nutraceuticals: A New Challenge against Cadmium-Induced Testicular Injury" Nutrients 14, no. 3: 663. https://doi.org/10.3390/nu14030663

APA Style

Marini, H. R., Micali, A., Squadrito, G., Puzzolo, D., Freni, J., Antonuccio, P., & Minutoli, L. (2022). Nutraceuticals: A New Challenge against Cadmium-Induced Testicular Injury. Nutrients, 14(3), 663. https://doi.org/10.3390/nu14030663

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop